Literature DB >> 10450681

Impact of attenuation correction by simultaneous emission/transmission tomography on visual assessment of 201Tl myocardial perfusion images.

R Vidal1, I Buvat, J Darcourt, O Migneco, P Desvignes, M Baudouy, F Bussière.   

Abstract

UNLABELLED: It has been shown in clinical studies that for subjects with a low likelihood of coronary artery disease (CAD), attenuation correction (AC) improves the specificity of defect detection in the inferior wall (right coronary artery [RCA] region). The aim of this study was to investigate the effect of AC on the visual interpretation of the RCA and anteroseptal (corresponding to the left anterior descending artery [LAD]) regions in CAD patients.
METHODS: Fifty-six patients with suspected CAD underwent 20Tl stress/4 h-delayed imaging SPECT using a simultaneous 201Tl emission/99mTc transmission imaging protocol. Images were reconstructed using the maximum likelihood-expectation maximum algorithm without and with AC. The stress/4 h-delayed images were interpreted blindly for reversible or fixed defects in the RCA and LAD regions by three experienced physicians. Coronary angiography, electrocardiography and enzyme findings were used to establish diagnoses of ischemia or infarction, and receiver operating characteristic (ROC) analyses were performed.
RESULTS: Statistical testing of ROC curve areas showed that defect detection performance improved with AC when compared with performance without AC in the RCA region. This was mainly the result of a systematic increase in specificity of 12% or more (for any observer and any type of defect) for a similar sensitivity (no definite change in sensitivity values). However, defect detection performance significantly decreased in the LAD territory with AC images (P < 0.05) because of a systematic decrease in sensitivity of 20% or more, with no consistent change in specificity. Similar trends were observed when reversible and fixed defects were considered separately.
CONCLUSION: AC significantly affects the visual interpretation of 201Tl stress/4 h-delayed SPECT images. This study confirmed the increase in specificity obtained with AC in the RCA territory. However, in the population considered, the studied AC was deleterious for the LAD territory assessment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450681

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

1.  The value and practice of attenuation correction for myocardial perfusion SPECT imaging: a joint position statement from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine.

Authors:  Robert C Hendel; James R Corbett; S James Cullom; E Gordon DePuey; Ernest V Garcia; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  Effect of attenuation correction on the interpretation of 99mTc-sestamibi myocardial perfusion scintigraphy: the impact of 1 year's experience.

Authors:  Riemer H J A Slart; Tjin H Que; Dirk J van Veldhuisen; Lieke Poot; Paul K Blanksma; D Albert Piers; Pieter L Jager
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-27       Impact factor: 9.236

3.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

4.  Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation.

Authors:  Yasmin Masood; Yi-Hwa Liu; Gordon Depuey; Raymond Taillefer; Luis I Araujo; Steven Allen; Dominique Delbeke; Frank Anstett; Aharon Peretz; Mary-Jo Zito; Vera Tsatkin; Frans J Th Wackers
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

5.  Improved coronary disease detection with quantitative attenuation-corrected Tl-201 images.

Authors:  Mathew Shotwell; Balkrishna M Singh; Charlotte Fortman; Brian D Bauman; Jennifer Lukes; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

6.  Clinical value of supine and upright myocardial perfusion imaging in obese patients using the D-SPECT camera.

Authors:  Simona Ben-Haim; Omar Almukhailed; Johanne Neill; Piotr Slomka; Rayjanah Allie; Dalia Shiti; Daniel S Berman; Jamshed Bomanji
Journal:  J Nucl Cardiol       Date:  2014-01-30       Impact factor: 5.952

7.  Contributions of subdiaphragmatic activity, attenuation, and diaphragmatic motion to inferior wall artifact in attenuation-corrected Tc-99m myocardial perfusion SPECT.

Authors:  Alexander G Pitman; Victor Kalff; Bruce Van Every; Borghild Risa; Leighton R Barnden; Michael J Kelly
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

8.  The influence of attenuation and scatter compensation on the apparent distribution of Tc-99m sestamibi in cardiac slices.

Authors:  P H Pretorius; M V Narayanan; S T Dahlberg; J A Leppo; M A King
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

9.  Scatter and attenuation correction changes interpretation of gated myocardial perfusion imaging.

Authors:  Allan Johansen; Peter Grupe; Annegrete Veje; Poul-Erik Nielsen Braad; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-29       Impact factor: 9.236

10.  Clinical value of attenuation correction in stress-only Tc-99m sestamibi SPECT imaging.

Authors:  Gary V Heller; Timothy M Bateman; Lynne L Johnson; S James Cullom; James A Case; James R Galt; Ernest V Garcia; Keith Haddock; Kelly L Moutray; Carlos Poston; Eli H Botvinick; Matthews B Fish; William P Follansbee; Sean Hayes; Ami E Iskandrian; John J Mahmarian; William Vandecker
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.